Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69].

Autor:	Akagi EM; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., de Sá Júnior PL; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., Simons SM; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., Bellini MH; Institute of Energy and Nuclear Research, IPEN, São Paulo, Brazil., Barreto SA; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., Chudzinski-Tavassi AM; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil. Electronic address: ana.chudzinski@butantan.gov.br.
Jazyk:	angličtina
Zdroj:	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2019 Oct; Vol. 118, pp. 109108. Date of Electronic Publication: 2019 Jun 22.
DOI:	10.1016/j.biopha.2019.109108
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect